1 Segalés J, Allan G, Domingo M. Circoviruses. Zimmerman J, Karriker LA, Ramirez A, et al., eds. Diseases of swine (11th Edition) 2019;473–487.
2 Madson D. Porcine circoviruses: Are changes occurring?, in Proceedings. AASV 50th Annual Meeting 2019;5–8.
3Payne B, Jacobs, Dvorak C, et al. PCV2 vaccine cross-protection: Identification of sequences in successfully vaccinated field cases, in Proceedings. AASV Annual Meeting 2016;202–206.
4 Fano E, Schaefer N, Schmaling E, et al. Comparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposure, in Proceedings. AASV Annu Meet 2017;95–97.
5 Fano E et al. Comparison of efficacy between two PCV2 vaccines under PCV2d experimental exposure, in Proceedings. AASV 2021.
6 Philips R, Fano E, Schmaling E, Edler R. A severe PRDC challenge and the effect of a trivalent PRDC vaccine for PCV2, Mhp and PRRS. Boehringer Ingelheim Vetmedica, Inc., Health Management Center (HMC), Field Research Services. 2018.
7 Friedrich R, Patterson AR, Johnson W, et al. Efficacy of porcine circovirus Type 2a– and 2d– based vaccines following PCV2 challenge. J Vaccines Vaccination 2019;10(2):1–5.